Insufficient scRNA-seq data for expression of HAP1 at single-cell level.
Insufficient scRNA-seq data for expression of HAP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2091.21 | 2633 / 2642 | 99% | 22.40 | 697 / 705 |
uterus | 81% | 649.18 | 137 / 170 | 59% | 5.13 | 270 / 459 |
thymus | 96% | 976.36 | 628 / 653 | 39% | 4.17 | 235 / 605 |
spleen | 90% | 618.36 | 216 / 241 | 0% | 0 | 0 / 0 |
prostate | 76% | 316.08 | 186 / 245 | 13% | 0.18 | 63 / 502 |
intestine | 74% | 266.61 | 715 / 966 | 8% | 0.41 | 44 / 527 |
tonsil | 0% | 0 | 0 / 0 | 82% | 7.40 | 37 / 45 |
esophagus | 23% | 56.02 | 334 / 1445 | 58% | 4.78 | 106 / 183 |
lung | 41% | 128.62 | 235 / 578 | 40% | 5.74 | 465 / 1155 |
kidney | 64% | 281.35 | 57 / 89 | 13% | 0.45 | 116 / 901 |
adrenal gland | 15% | 48.81 | 39 / 258 | 59% | 3.98 | 136 / 230 |
skin | 49% | 145.15 | 886 / 1809 | 21% | 0.76 | 97 / 472 |
ovary | 46% | 157.97 | 83 / 180 | 9% | 0.24 | 40 / 430 |
breast | 37% | 195.39 | 169 / 459 | 17% | 0.51 | 188 / 1118 |
pancreas | 19% | 43.96 | 62 / 328 | 29% | 4.22 | 52 / 178 |
bladder | 19% | 32.81 | 4 / 21 | 28% | 1.95 | 142 / 504 |
stomach | 19% | 80.75 | 70 / 359 | 12% | 0.44 | 35 / 286 |
adipose | 10% | 30.94 | 122 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 10% | 0.28 | 8 / 80 |
liver | 3% | 4.47 | 6 / 226 | 5% | 0.20 | 20 / 406 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
muscle | 1% | 1.80 | 7 / 803 | 0% | 0 | 0 / 0 |
heart | 0% | 0.17 | 1 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.18 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008090 | Biological process | retrograde axonal transport |
GO_0048011 | Biological process | neurotrophin TRK receptor signaling pathway |
GO_0008089 | Biological process | anterograde axonal transport |
GO_1902430 | Biological process | negative regulation of amyloid-beta formation |
GO_0048311 | Biological process | mitochondrion distribution |
GO_0050769 | Biological process | positive regulation of neurogenesis |
GO_0017157 | Biological process | regulation of exocytosis |
GO_0021979 | Biological process | hypothalamus cell differentiation |
GO_0030030 | Biological process | cell projection organization |
GO_0006605 | Biological process | protein targeting |
GO_0031587 | Biological process | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity |
GO_0032901 | Biological process | positive regulation of neurotrophin production |
GO_0098957 | Biological process | anterograde axonal transport of mitochondrion |
GO_0045742 | Biological process | positive regulation of epidermal growth factor receptor signaling pathway |
GO_0022008 | Biological process | neurogenesis |
GO_0006887 | Biological process | exocytosis |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0021549 | Biological process | cerebellum development |
GO_0007420 | Biological process | brain development |
GO_1902857 | Biological process | positive regulation of non-motile cilium assembly |
GO_0015031 | Biological process | protein transport |
GO_0006914 | Biological process | autophagy |
GO_0008104 | Biological process | protein localization |
GO_0032230 | Biological process | positive regulation of synaptic transmission, GABAergic |
GO_1902513 | Biological process | regulation of organelle transport along microtubule |
GO_0047496 | Biological process | vesicle transport along microtubule |
GO_0005730 | Cellular component | nucleolus |
GO_0005856 | Cellular component | cytoskeleton |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0043197 | Cellular component | dendritic spine |
GO_0005739 | Cellular component | mitochondrion |
GO_0005769 | Cellular component | early endosome |
GO_0005813 | Cellular component | centrosome |
GO_0005764 | Cellular component | lysosome |
GO_0030425 | Cellular component | dendrite |
GO_0005814 | Cellular component | centriole |
GO_0016234 | Cellular component | inclusion body |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0030426 | Cellular component | growth cone |
GO_0005776 | Cellular component | autophagosome |
GO_1904115 | Cellular component | axon cytoplasm |
GO_0017022 | Molecular function | myosin binding |
GO_0048403 | Molecular function | brain-derived neurotrophic factor binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0005515 | Molecular function | protein binding |
Gene name | HAP1 |
Protein name | Huntingtin-associated protein 1 (HAP-1) (Neuroan 1) Huntingtin associated protein 1 |
Synonyms | HAP2 HLP1 |
Description | FUNCTION: Originally identified as neuronal protein that specifically associates with HTT/huntingtin and the binding is enhanced by an expanded polyglutamine repeat within HTT possibly affecting HAP1 interaction properties. Both HTT and HAP1 are involved in intracellular trafficking and HAP1 is proposed to link HTT to motor proteins and/or transport cargos. Seems to play a role in vesicular transport within neurons and axons such as from early endosomes to late endocytic compartments and to promote neurite outgrowth. The vesicular transport function via association with microtubule-dependent transporters can be attenuated by association with mutant HTT. Involved in the axonal transport of BDNF and its activity-dependent secretion; the function seems to involve HTT, DCTN1 and a complex with SORT1. Involved in APP trafficking and seems to facilitate APP anterograde transport and membrane insertion thereby possibly reducing processing into amyloid beta. Involved in delivery of gamma-aminobutyric acid (GABA(A)) receptors to synapses; the function is dependent on kinesin motor protein KIF5 and is disrupted by HTT with expanded polyglutamine repeat. Involved in regulation of autophagosome motility by promoting efficient retrograde axonal transport. Seems to be involved in regulation of membrane receptor recycling and degradation, and respective signal transduction, including GABA(A) receptors, tyrosine kinase receptors, EGFR, IP3 receptor and androgen receptor. Among others suggested to be involved in control of feeding behavior (involving hypothalamic GABA(A) receptors), cerebellar and brainstem development (involving AHI1 and NTRK1/TrkA), postnatal neurogenesis (involving hypothalamic NTRK2/TrkB), and ITPR1/InsP3R1-mediated Ca(2+) release (involving HTT and possibly the effect of mutant HTT). Via association with DCTN1/dynactin p150-glued and HTT/huntingtin involved in cytoplasmic retention of REST in neurons. May be involved in ciliogenesis. Involved in regulation of exocytosis. Seems to be involved in formation of cytoplasmic inclusion bodies (STBs). In case of anomalous expression of TBP, can sequester a subset of TBP into STBs; sequestration is enhanced by an expanded polyglutamine repeat within TBP. HAP1-containing STBs have been proposed to play a protective role against neurodegeneration in Huntigton disease (HD) and spinocerebellar ataxia 17 (SCA17). . |
Accessions | H7C295 ENST00000442364.1 ENST00000393939.6 [P54257-3] ENST00000455021.5 P54257 ENST00000458656.5 ENST00000347901.9 [P54257-2] H7C0W9 H7BZC9 ENST00000310778.5 [P54257-1] ENST00000341193.9 [P54257-4] |